Results 141 to 150 of about 3,573 (200)

Injection-Based Therapies for Migraine in Older Adults: A Narrative Review of OnabotulinumtoxinA, Greater Occipital Nerve Block, and Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies. [PDF]

J Korean Med Sci
Kang MK, Cho S, Kim BK, Moon HS, Lee MJ, Kim SK, Park HK, Chu MK, Ha WS, Kim BS, Cho SJ.   +10 more
europepmc   +1 more source

Complete Resolution of New Daily Persistent Headache With Migraine-Like Features Following Erenumab Treatment: A Case Report. [PDF]

Cureus
Kikui S, Danno D, Takeshima T.
europepmc   +1 more source

Single-residue engineering of lambda (λ) antibody light chains reduces conformational flexibility and enhances thermal stability. [PDF]

Comput Struct Biotechnol J
Jewel Y, Young T, Park M, Ly K, Gonzalez A, Mallett TC, Williams JC.   +6 more
europepmc   +1 more source

Clinical predictors for efficacy of erenumab for migraine: a Registry for Migraine (REFORM) study. [PDF]

Brain Commun
Karlsson WK, Ashina M, Christensen RH, Al-Khazali HM, Ashina H.   +4 more
europepmc   +1 more source

No Increase in Blood Pressure Assessed With the 24-h Holter Monitoring in Patients With Episodic Migraine During Early Treatment With Anti-CGRP Monoclonal Antibodies: A Prospective Observational Study (SAFHYPER). [PDF]

Eur J Neurol
Lo Castro F, Bonini N, Iannone LF, Boccalini A, Brovia D, Pani L, Boriani G, Guerzoni S.   +7 more
europepmc   +1 more source

Potential drug interaction between calcitonin gene-related peptide antagonists and neonatal Fc receptor inhibitors. [PDF]

Headache
Harlan A, Weber K.
europepmc   +1 more source

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response. [PDF]

J Headache Pain
Muñoz-Vendrell A, Campoy-Díaz S, Valín-Villanueva P, Casas-Limón J, Fernández-Lázaro I, González-García N, Santos-Lasaosa S, González Osorio Y, Gonzalez-Martinez A, Campdelacreu J, Portocarrero-Sánchez L, Cano Sánchez LM, García Sánchez SM, Pérez-de-la-Parte A, Morollón Sánchez-Mateos N, López-Bravo A, Mínguez-Olaondo A, Sánchez-Soblechero A, Lozano Ros A, Morales Hernández C, Andrés López A, Layos-Romero A, Caronna E, Torres-Ferrús M, Alpuente A, Pozo-Rosich P, Belvís R, Garcia-Azorin D, Díaz-de-Terán J, Guerrero-Peral ÁL, Gago-Veiga AB, Huerta-Villanueva M.   +31 more
europepmc   +1 more source

The vessel-to-neuron trigeminovascular hypothesis of migraine pathogenesis - the 'pro' argument. [PDF]

J Headache Pain
Christensen RH, Ashina H, Ashina M.
europepmc   +1 more source

Effect of Biological Therapy on Symptom Burden and Functional Disability in Patients with Migraine: A Before-and-After Analysis. [PDF]

Zdr Varst
Ličina A, Fabjan A, Žibert J, Kamenšek T.   +3 more
europepmc   +1 more source

Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study. [PDF]

Neurology
Lusk JB, Wilson LE, Moore C, Yarnell S, Kalapura C, Choudhury A, Schrag M, Poli S, Li F, Mac Grory B.   +9 more
europepmc   +1 more source